Prostate Cancer - Results from #24960

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer - Abstract August 27, 2012

Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging - Abstract August 27, 2012

Redefining micrometastasis in prostate cancer - a comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatecto August 27, 2012

Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant - Abstract August 27, 2012

High-dose 3D-CRT in the radical and postoperative setting for prostate cancer. Analysis of survival and late rectal and urinary toxicity - Abstract August 27, 2012

A case of small cell carcinoma of the prostate and review of the literature - Abstract August 27, 2012

Informed decision making about prostate cancer testing in predominantly immigrant black men: A randomized controlled trial - Abstract August 27, 2012

Neighbourhoods matter too: The association between neighbourhood socioeconomic position, population density and breast, prostate and lung cancer incidence in Denmark between 2004 and 2008 - Abstract August 27, 2012

Molecular imaging of prostate cancer: PET radiotracers - Abstract August 27, 2012

The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: Effect of reader experience - Abstract August 27, 2012

Atypical metastases from prostate cancer: 10-Year experience at a single institution - Abstract August 27, 2012

A changing landscape in castration-resistant prostate cancer treatment - Abstract August 27, 2012

Prostate cancer dependance upon cholesterol, statins and diet - Abstract August 27, 2012

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy - Abstract August 25, 2012

Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer - Abstract August 25, 2012

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy - Abstract August 25, 2012

Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: Results from the California Collaborative Prostate Cancer Study - Abstract August 25, 2012

Limited PSA testing in indigent men in South Texas: An appropriate care or missing a prevention opportunity? - Abstract August 25, 2012

Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes - Abstract August 24, 2012

Monitoring potential prostate cancer biomarkers in urine by capillary electrophoresis-tandem mass spectrometry - Abstract August 24, 2012

Page 1249 of 1435